Wall Street Grand About Us

Featured Small Cap Stock Profiles

Stock Market Multimedia Section

Investment Information & Resources

Small-Cap Investment Services

Wall Street Grand Contact Information

 

Explosive penny stock list for those looking for huge gains! Join our FREE newsletter and find out why our members are consistently receiving penny stock picks that make BIG profits!

 

 

 

"Wall Street Grand Releases a Brand New Must See Economic Documentary Titled 'Melt Up'"
Featuring an Exclusive interview with Gerald Celente, along with Peter Schiff, Ron Paul, Michael Lewis, Alex Jones, John Williams and more...

Recent WSG Performance:      GULF RESOURCES - GFRE $11.49 (+1251%)      APOLLO GOLD - AGT $0.59 (+392%)      GREEN STAR - GSAE $1.79 (+795%)      IVANHOE MINES - IVN $14.94 (+259%)      FRESHWATER - FWTC $0.20 (+471%)      CHINA AGRITECH - CAGC $31.44 (+1037%)      BULLION MONARCH - BULM $0.97 (+177%)      BIONEUTRAL GROUP - BONU $3.50 (+695%)      LINKWELL CORP - LWLL $0.24 (+380%)      DRD GOLD LIMITED - DROOY $10.59 (+220%)      JAGUAR MINING - JAG $12.76 (+465%)      AGFEED INDUSTRIES - FEED $7.96 (+512%)

    

    Echo Therapeutics inc. - Stock Symbol: (ECTE.OB)

 

    Visit Company Website: http://www.echotx.com

 

 

 

 

ECTE is our new Bio-tech Play!

ECTE is penetrating the multi-BILLION Diabetes market! This Company has a revolutionary, PATENTED, one-of-a-kind diabetes monitoring system that uses a proprietary needle-free platform technology! I don't know if you know anyone who has diabetes but they will tell you how BIG this first to market product could become. Imagine if your child had diabetes and you had to give a needle to them every single day. I have many friends that have to go through this and it is very hard for them. Now imagine a company that has a patented and proprietary product that can eliminate this process and use a NEEDLE-FREE monitoring system! Well we found the Company that has this revolutionary technology and it's taking off RIGHT NOW!

 

 

 

 

 

ECTE is EXPLODING and could become a major acquisition target!

ECTE  is a transdermal medical device company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System as a platform technology for transdermal drug delivery!

ECTE believes that the Symphony tCGM System will change the paradigm of invasive, needle-based,  pisodic glucose testing in the diabetes consumer and hospital critical care markets to one of continuous, needle-free monitoring.

This is a MULTI-BILLION dollar market!!!

ECTE is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation to allow for transdermal drug delivery of a wide range of FDA-approved products! ECTE believes that the Symphony system is an ideal solution for diabetics and critically ill patients allowing for continuous, pain-free monitoring of glucose levels.

The continuous monitoring will enable more accurate management of diabetes (resulting in healthier outcomes) and higher compliance compared to painful, invasive methods for drawing blood today.

ECTE also believes that its Prelude SkinPrep System will allow many drugs currently delivered by needle injection to be administered without a needle by using Prelude prior to transdermal drug administration.

This alone could add substantial value to ECTE in the short-term!

----------------------------------

ECTE's $15 Million Agreement

ECTE has signed a $15 million agreement, giving Ferndale Pharmaceuticals a license to develop, market and sell Prelude for enhanced delivery of Ferndales topical lidocaine product, LMX4, in North America and the UK. Echo received $750,000 up front and will receive $750,000 upon FDA approval, as well as $12.5 million in milestones and guaranteed minimum royalty payments. Echo will also receive a double digit royalty on net sales of the product.                        

ECTE could really start top breakout over the next couple of days so start your research tonight and get ready for a big day tomorrow!

 

 

If you have questions or comments please give us a call during market hours at 1-(888)-925-8247. Please Help spread the Word!!

MORE UPDATES TO COME...

If you have any questions feel free to email me or call us at 1-(888)-9-Club Grand -or- staff@wallstreetgrand.com

Wall Street Grand's stock profiles are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment. WSG was compensated $25,000 for profile coverage of ECTE by a third party, (GreenHorshoe Holdings Inc.). WSG may or may not trade the stocks mentioned in this alert which can effect the price of the stock. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country Everything stated in WSG alerts are based on my opinion. For our full disclosure please visit- http://www.wallstreetgrand.com/disclosure.html

 

 
 

Print This PageAdd to FavoritesShare This PageStock Profiles PageMultimedia PageWSG HomepageContact Us

 


Home  I  Member Sign-Up  I  List of Penny Stocks  I  Investor Multimedia  I  Stock Alert Archive  I  Wall Street News  I  Investment Services  I  Contact

Copyright 2004 - 2010 Wall Street Grand LLC. All Rights Reserved.  Privacy Policy  I  Disclosure  I  Links  I  Online Brokers  I  Site Map